Journal of Clinical Endocrinology & Metabolism, Vol 76, 1407-1412, Copyright © 1993 by Endocrine Society

ARTICLES

Activation of the somatotropic axis by testosterone in adult males: evidence for the role of aromatization

AJ Weissberger and KK Ho
Garvan Institute of Medical Research, St. Vincent's Hospital, Sydney, NSW, Australia.

To determine whether testosterone modulates the somatotropic axis in adult males, we compared 24-h GH secretion (from 20-min sampling, using Cluster analysis) and insulin-like growth factor-I (IGF-I) levels of five hypogonadal men (aged 20-32 yr) with those of six normal men (aged 21-27 yr), and examined the effects of testosterone replacement (testosterone enanthate 250 mg im monthly). To elucidate whether the action of testosterone on the somatotropic axis is direct, or requires the aromatization of testosterone to estradiol, we also examined the effects of the nonsteroidal antiestrogen, tamoxifen (20 mg/day for 3 weeks), on 24-h GH secretion and IGF-I levels in the normal men and in four of the hypogonadal men during concurrent testosterone treatment. Compared to the normal men, the hypogonadal men had significantly reduced mean GH pulse amplitude (3.1 +/- 0.6 vs. 8.4 +/- 1.7 micrograms/L, P < 0.05), but not pulse frequency. Testosterone treatment resulted in a significant increase in 24-h mean serum GH (0.7 +/- 0.2 to 1.4 +/- 0.2 micrograms/L, P < 0.05), mean GH pulse amplitude (3.1 +/- 0.6 to 5.2 +/- 0.8 micrograms/L, P < 0.01) and serum IGF-I (0.9 +/- 0.1 to 1.1 +/- 0.1 U/mL, P < 0.05). In the normal men, tamoxifen significantly reduced 24-h mean serum GH (1.1 +/- 0.3 to 0.5 +/- 0.1 micrograms/L, P < 0.05), mean GH pulse amplitude (8.4 +/- 1.7 to 4.7 +/- 0.4 micrograms/L, P < 0.05), and serum IGF-I (1.0 +/- 0.1 to 0.7 +/- 0.1 U/mL, P < 0.001). In the hypogonadal men on testosterone replacement, tamoxifen lowered 24-h mean serum GH (1.3 +/- 0.2 to 0.6 +/- 0.2 micrograms/L, P < 0.01), mean GH pulse amplitude (5.5 +/- 1.0 to 2.4 +/- 0.8 micrograms/L, P < 0.01), and serum IGF-I (1.2 +/- 0.1 to 0.8 +/- 0.1 U/mL, P < 0.05). We conclude that testosterone plays an important role in the modulation of the male somatotropic axis in adulthood, as appears to be the case in puberty, and that this effect is partly dependent on the aromatization of testosterone to estradiol.

This article has been cited by other articles:

				J. D. Veldhuis and C. Y. Bowers Factors Other than Sex Steroids Modulate GHRH and GHRP-2 Efficacies in Men: Evaluation Using a GnRH Agonist/Testosterone Clamp J. Clin. Endocrinol. Metab., July 1, 2009; 94(7): 2544 - 2550. [Abstract] [Full Text] [PDF]

				J. D. Veldhuis, K. L. Mielke, M. Cosma, C. Soares-Welch, R. Paulo, J. M. Miles, and C. Y. Bowers Aromatase and 5{alpha}-Reductase Inhibition during an Exogenous Testosterone Clamp Unveils Selective Sex Steroid Modulation of Somatostatin and Growth Hormone Secretagogue Actions in Healthy Older Men J. Clin. Endocrinol. Metab., March 1, 2009; 94(3): 973 - 981. [Abstract] [Full Text] [PDF]

				J. D. Veldhuis, D. M. Keenan, J. N. Bailey, A. Adeniji, J. M. Miles, R. Paulo, M. Cosma, and C. Soares-Welch Testosterone Supplementation in Older Men Restrains Insulin-Like Growth Factor's Dose-Dependent Feedback Inhibition of Pulsatile Growth Hormone Secretion J. Clin. Endocrinol. Metab., January 1, 2009; 94(1): 246 - 254. [Abstract] [Full Text] [PDF]

				A. L. Utz, A. Yamamoto, P. Sluss, J. Breu, and K. K. Miller Androgens May Mediate a Relative Preservation of IGF-I Levels in Overweight and Obese Women Despite Reduced Growth Hormone Secretion J. Clin. Endocrinol. Metab., October 1, 2008; 93(10): 4033 - 4040. [Abstract] [Full Text] [PDF]

				R. Muniyappa, J. D. Sorkin, J. D. Veldhuis, S. M. Harman, T. Munzer, S. Bhasin, and M. R. Blackman Long-term testosterone supplementation augments overnight growth hormone secretion in healthy older men Am J Physiol Endocrinol Metab, September 1, 2007; 293(3): E769 - E775. [Abstract] [Full Text] [PDF]

				K.-C. Leung, J. Brce, N. Doyle, H. J. Lee, G. M. Leong, K. Sjogren, and K. K. Y. Ho Regulation of Growth Hormone Signaling by Selective Estrogen Receptor Modulators Occurs through Suppression of Protein Tyrosine Phosphatases Endocrinology, May 1, 2007; 148(5): 2417 - 2423. [Abstract] [Full Text] [PDF]

				T. Kvorning, M. Andersen, K. Brixen, and K. Madsen Suppression of endogenous testosterone production attenuates the response to strength training: a randomized, placebo-controlled, and blinded intervention study Am J Physiol Endocrinol Metab, December 1, 2006; 291(6): E1325 - E1332. [Abstract] [Full Text] [PDF]

				C K Hilleson-Gayne and J A Clapper Effects of decreased estradiol-17{beta} on the serum and anterior pituitary IGF-I system in pigs J. Endocrinol., December 1, 2005; 187(3): 369 - 378. [Abstract] [Full Text] [PDF]

				C. A. Blake, L. M. Brown, M. W. Duncan, S. W. Hunsucker, and S. M. Helmke Estrogen Regulation of the Rat Anterior Pituitary Gland Proteome Experimental Biology and Medicine, December 1, 2005; 230(11): 800 - 807. [Abstract] [Full Text] [PDF]

				J. Gibney, T. Wolthers, G. Johannsson, A. M. Umpleby, and K. K. Y. Ho Growth hormone and testosterone interact positively to enhance protein and energy metabolism in hypopituitary men Am J Physiol Endocrinol Metab, August 1, 2005; 289(2): E266 - E271. [Abstract] [Full Text] [PDF]

				G. Johannsson, J. Gibney, T. Wolthers, K.-C. Leung, and K. K. Y. Ho Independent and Combined Effects of Testosterone and Growth Hormone on Extracellular Water in Hypopituitary Men J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 3989 - 3994. [Abstract] [Full Text] [PDF]

				S. W. van Thiel, J. A. Romijn, A. M. Pereira, N. R. Biermasz, F. Roelfsema, A. van Hemert, B. Ballieux, and J. W. A. Smit Effects of Dehydroepiandrostenedione, Superimposed on Growth Hormone Substitution, on Quality of Life and Insulin-Like Growth Factor I in Patients with Secondary Adrenal Insufficiency: A Randomized, Placebo-Controlled, Cross-Over Trial J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3295 - 3303. [Abstract] [Full Text] [PDF]

				K.-C. Leung, G. Johannsson, G. M. Leong, and K. K. Y. Ho Estrogen Regulation of Growth Hormone Action Endocr. Rev., October 1, 2004; 25(5): 693 - 721. [Abstract] [Full Text] [PDF]

				J. J. Orrego, E. Dimaraki, K. Symons, and A. L. Barkan Physiological Testosterone Replenishment in Healthy Elderly Men Does Not Normalize Pituitary Growth Hormone Output: Evidence against the Connection between Senile Hypogonadism and Somatopause J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3255 - 3260. [Abstract] [Full Text] [PDF]

				S. Schurgin, S. Dolan, A. Perlstein, M. P. Sullivan, N. Aliabadi, and S. Grinspoon Effects of Testosterone Administration on Growth Hormone Pulse Dynamics in Human Immunodeficiency Virus-Infected Women J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3290 - 3297. [Abstract] [Full Text] [PDF]

				D. Vanderschueren, L. Vandenput, S. Boonen, M. K. Lindberg, R. Bouillon, and C. Ohlsson Androgens and Bone Endocr. Rev., June 1, 2004; 25(3): 389 - 425. [Abstract] [Full Text] [PDF]

				K. F. Adams, K. M. Newton, C. Chen, S. S. Emerson, J. D. Potter, E. White, and J. W. Lampe Soy Isoflavones Do Not Modulate Circulating Insulin-Like Growth Factor Concentrations in an Older Population in an Intervention Trial J. Nutr., May 1, 2003; 133(5): 1316 - 1319. [Abstract] [Full Text] [PDF]

				K.-C. Leung, C. Howe, L. Y.-Y. Gui, G. Trout, J. D. Veldhuis, and K. K. Y. Ho Physiological and pharmacological regulation of 20-kDa growth hormone Am J Physiol Endocrinol Metab, October 1, 2002; 283(4): E836 - E843. [Abstract] [Full Text] [PDF]

				E. Richmond, A. D. Rogol, D. Basdemir, O. L. Veldhuis, W. Clarke, C. Y. Bowers, and J. D. Veldhuis Accelerated Escape from GH Autonegative Feedback in Midpuberty in Males: Evidence for Time-Delimited GH-Induced Somatostatinergic Outflow in Adolescent Boys J. Clin. Endocrinol. Metab., August 1, 2002; 87(8): 3837 - 3844. [Abstract] [Full Text] [PDF]

				G. Johannsson, P. Burman, L. Wiren, B. E. Engstrom, A. G. Nilsson, M. Ottosson, B. Jonsson, B.-A. Bengtsson, and F. A. Karlsson Low Dose Dehydroepiandrosterone Affects Behavior in Hypopituitary Androgen-Deficient Women: A Placebo-Controlled Trial J. Clin. Endocrinol. Metab., May 1, 2002; 87(5): 2046 - 2052. [Abstract] [Full Text] [PDF]

				A. M. Matsumoto Andropause: Clinical Implications of the Decline in Serum Testosterone Levels With Aging in Men J. Gerontol. A Biol. Sci. Med. Sci., February 1, 2002; 57(2): M76 - 99. [Full Text]

				C. Lofqvist, E. Andersson, L. Gelander, S. Rosberg, W. F. Blum, and K. A. Wikland Reference Values for IGF-I throughout Childhood and Adolescence: A Model that Accounts Simultaneously for the Effect of Gender, Age, and Puberty J. Clin. Endocrinol. Metab., December 1, 2001; 86(12): 5870 - 5876. [Abstract] [Full Text] [PDF]

				R. J. Saad, B. S. Keenan, K. Danadian, V. D. Lewy, and S. A. Arslanian Dihydrotestosterone Treatment in Adolescents with Delayed Puberty: Does it Explain Insulin Resistance of Puberty? J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 4881 - 4886. [Abstract] [Full Text] [PDF]

				J. A. Schnorr, M. J. Bray, and J. D. Veldhuis Aromatization Mediates Testosterone's Short-Term Feedback Restraint of 24-Hour Endogenously Driven and Acute Exogenous Gonadotropin-Releasing Hormone-Stimulated Luteinizing Hormone and Follicle-Stimulating Hormone Secretion in Young Men J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2600 - 2606. [Abstract] [Full Text] [PDF]

				K. K. Miller, G. Sesmilo, A. Schiller, D. Schoenfeld, S. Burton, and A. Klibanski Androgen Deficiency in Women with Hypopituitarism J. Clin. Endocrinol. Metab., February 1, 2001; 86(2): 561 - 567. [Abstract] [Full Text]

				M. Maccario, G. Aimaretti, G. Corneli, C. Gauna, S. Grottoli, M. Bidlingmaier, C. J. Strasburger, C. Dieguez, F. F. Casanueva, and E. Ghigo Short-term fasting abolishes the sex-related difference in GH and leptin secretion in humans Am J Physiol Endocrinol Metab, August 1, 2000; 279(2): E411 - E416. [Abstract] [Full Text] [PDF]

				O. Vidal, M. K. Lindberg, K. Hollberg, D. J. Baylink, G. Andersson, D. B. Lubahn, S. Mohan, J.-A. Gustafsson, and C. Ohlsson Estrogen receptor specificity in the regulation of skeletal growth and maturation in male mice PNAS, May 9, 2000; 97(10): 5474 - 5479. [Abstract] [Full Text] [PDF]

				G. Van den Berghe, R. C. Baxter, F. Weekers, P. Wouters, C. Y. Bowers, and J. D. Veldhuis A Paradoxical Gender Dissociation within the Growth Hormone/Insulin-Like Growth Factor I Axis during Protracted Critical Illness J. Clin. Endocrinol. Metab., January 1, 2000; 85(1): 183 - 192. [Abstract] [Full Text]

				J. R. Center, T. V. Nguyen, P. N. Sambrook, and J. A. Eisman Hormonal and Biochemical Parameters in the Determination of Osteoporosis in Elderly Men J. Clin. Endocrinol. Metab., October 1, 1999; 84(10): 3626 - 3635. [Abstract] [Full Text] [PDF]

				N. Shah, W. S. Evans, and J. D. Veldhuis Actions of estrogen on pulsatile, nyctohemeral, and entropic modes of growth hormone secretion Am J Physiol Regulatory Integrative Comp Physiol, May 1, 1999; 276(5): R1351 - R1358. [Abstract] [Full Text] [PDF]

				A. Giustina and J. D. Veldhuis Pathophysiology of the Neuroregulation of Growth Hormone Secretion in Experimental Animals and the Human Endocr. Rev., December 1, 1998; 19(6): 717 - 797. [Abstract] [Full Text]

				S. Grinspoon, C. Corcoran, T. Stanley, L. Katznelson, and A. Klibanski Effects of Androgen Administration on the Growth Hormone-Insulin-Like Growth Factor I Axis in Men with Acquired Immunodeficiency Syndrome Wasting J. Clin. Endocrinol. Metab., December 1, 1998; 83(12): 4251 - 4256. [Abstract] [Full Text]

				B. M. Kudielka, J. Hellhammer, D. H. Hellhammer, O. T. Wolf, K.-M. Pirke, E. Varadi, J. Pilz, and C. Kirschbaum Sex Differences in Endocrine and Psychological Responses to Psychosocial Stress in Healthy Elderly Subjects and the Impact of a 2-Week Dehydroepiandrosterone Treatment J. Clin. Endocrinol. Metab., May 1, 1998; 83(5): 1756 - 1761. [Abstract] [Full Text]

				D. A. Fryburg, A. Weltman, L. A. Jahn, J. Y. Weltman, E. Samojlik, R. L. Hintz, and J. D. Veldhuis Short-Term Modulation of the Androgen Milieu Alters Pulsatile, But Not Exercise- or Growth Hormone (GH)-Releasing Hormone-Stimulated GH Secretion in Healthy Men: Impact of Gonadal Steroid and GH Secretory Changes on Metabolic Outcomes J. Clin. Endocrinol. Metab., November 1, 1997; 82(11): 3710 - 3719. [Abstract] [Full Text] [PDF]

				S. Arslanian and C. Suprasongsin Testosterone Treatment in Adolescents with Delayed Puberty: Changes in Body Composition, Protein, Fat, and Glucose Metabolism J. Clin. Endocrinol. Metab., October 1, 1997; 82(10): 3213 - 3220. [Abstract] [Full Text] [PDF]

				S. Loche, A. Colao, M. Cappa, J. Bellone, G. Aimaretti, G. Farello, A. Faedda, G. Lombardi, R. Deghenghi, and E. Ghigo The Growth Hormone Response to Hexarelin in Children: Reproducibility and Effect of Sex Steroids J. Clin. Endocrinol. Metab., March 1, 1997; 82(3): 861 - 864. [Abstract] [Full Text] [PDF]

				I. R. Reid, D. J. Wattie, M. C. Evans, and J. P. Stapleton Testosterone Therapy in Glucocorticoid-Treated Men Arch Intern Med, June 10, 1996; 156(11): 1173 - 1177. [Abstract] [PDF]